Cargando…

Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients

Molecular subtyping of breast cancer may provide additional prognostic information regarding patient outcome. However, its clinical significance remains to be established. In this study, the main aims were to discover whether reclassification of breast cancer into molecular subtypes provides more pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Engstrøm, M. J., Opdahl, S., Hagen, A. I., Romundstad, P. R., Akslen, L. A., Haugen, O. A., Vatten, L. J., Bofin, A. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2013
Materias:	Preclinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742963/ https://www.ncbi.nlm.nih.gov/pubmed/23901018 http://dx.doi.org/10.1007/s10549-013-2647-2

Ejemplares similares

Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes
por: Engstrøm, Monica J, et al.
Publicado: (2015)

MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypes
por: Klæstad, Elise, et al.
Publicado: (2020)

DTX3 copy number increase in breast cancer: a study of associations to molecular subtype, proliferation and prognosis
por: Valla, Marit, et al.
Publicado: (2021)

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
por: Lips, E. H., et al.
Publicado: (2013)

TOP2A gene copy number change in breast cancer
por: Engstrøm, M J, et al.
Publicado: (2014)

Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer
por: Verma, Rashmi, et al.
Publicado: (2020)

Enrichment of high-grade tumors in breast cancer gene expression studies
por: van Seijen, M., et al.
Publicado: (2017)

Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up
por: Yang, Sherry X., et al.
Publicado: (2019)

Retrospective analysis of metastatic behaviour of breast cancer subtypes
por: Savci-Heijink, C. Dilara, et al.
Publicado: (2015)

BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance
por: Kuilman, Midas M., et al.
Publicado: (2022)

The association of women’s birth size with risk of molecular breast cancer subtypes: a cohort study
por: Sandvei, Marie S., et al.
Publicado: (2021)

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis
por: Engels, C. C., et al.
Publicado: (2015)

Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile
por: Suelmann, B. B. M., et al.
Publicado: (2021)

Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes
por: Friedland, Julie C., et al.
Publicado: (2013)

Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns
por: Bardowell, Sabrina A., et al.
Publicado: (2013)

Micro-computed tomography enables rapid surgical margin assessment during breast conserving surgery (BCS): correlation of whole BCS micro-CT readings to final histopathology
por: McClatchy, David M., et al.
Publicado: (2018)

Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy
por: O’Toole, Sharon A., et al.
Publicado: (2020)

The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes
por: Althobiti, Maryam, et al.
Publicado: (2020)

Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer
por: Silva, Grace O., et al.
Publicado: (2015)

Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer
por: Dix-Peek, Thérèse, et al.
Publicado: (2023)

Intrinsic subtypes in Ethiopian breast cancer patient
por: Desalegn, Zelalem, et al.
Publicado: (2022)

CCND1 Amplification in Breast Cancer -associations With Proliferation, Histopathological Grade, Molecular Subtype and Prognosis
por: Valla, Marit, et al.
Publicado: (2022)

The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer
por: Hu, Jiayue, et al.
Publicado: (2023)

Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
por: Prat, Aleix, et al.
Publicado: (2013)

Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival
por: Joseph, Chitra, et al.
Publicado: (2020)

Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry
por: Wirtz, Ralph M., et al.
Publicado: (2016)

Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial
por: Strell, Carina, et al.
Publicado: (2021)

Expression of the BRCA1 complex member BRE predicts disease free survival in breast cancer
por: Noordermeer, Sylvie M., et al.
Publicado: (2012)

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
por: Jansson, Sara, et al.
Publicado: (2018)

A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women
por: Tseng, Ling-Ming, et al.
Publicado: (2017)

Assessing the role of tumour-associated macrophage subsets in breast cancer subtypes using digital image analysis
por: Zwager, Mieke C., et al.
Publicado: (2023)

Hypertensive diseases in pregnancy and breast cancer risk
por: Opdahl, S, et al.
Publicado: (2012)

Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors
por: Yeh, Elizabeth S., et al.
Publicado: (2014)

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer
por: Lipton, Allan, et al.
Publicado: (2013)

The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype
por: Tiainen, Satu, et al.
Publicado: (2020)

Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival
por: Weigman, Victor J., et al.
Publicado: (2011)

Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes
por: Teinturier, Romain, et al.
Publicado: (2021)

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer
por: Jansen, M. P. H. M., et al.
Publicado: (2011)

Joint effects of nulliparity and other breast cancer risk factors
por: Opdahl, S, et al.
Publicado: (2011)

Weight change in adulthood and risk of postmenopausal breast cancer: the HUNT study of Norway
por: Alsaker, M D K, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_72ebgq3qot57dvpkoa3lbp9glk